Literature DB >> 26029741

Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma Cells.

Diana L Borgas1, Jin-Song Gao1, Ming Tong1, Nitin Roper1, Suzanne M de la Monte1.   

Abstract

BACKGROUND: Asparaginyl-β-hydroxylase (AAH) promotes cell adhesion, migration, and invasion via Notch activation. AAH's expression is up-regulated by insulin/IGF signaling through PI3K-Akt, but its protein is independently regulated by GSK-3β. The multiple predicted GSK-3β phosphorylation sites suggest post-translational mechanisms may regulate AAH protein expression.
METHODS: Human Huh7 hepatoma cells were transfected with recombinant plasmids that expressed full-length N-terminal Myc-tagged (N-Myc-AAH) or C-terminal HA-tagged (C-HA-AAH) cDNA. Effects of IGF-1 on AAH protein were examined using cellular ELISAs, immunofluorescence, and Western blotting. Effects of kinase inhibitors relevant to AAH's predicted phosphorylation sites were studied.
RESULTS: IGF-1 stimulation increased AAH protein expression and shifted AAH's localization from the perinuclear zone to the cell periphery, including podocytes. Subsequently, Notch-1 intracellular domain was translocated to the nucleus, which is critical for Notch- modulated gene expression. Besides GSK-3β, inhibition of PKC, PKA, and CK2, which could potentially phosphorylate AAH, increased IGF-1 stimulated AAH protein. Finally, insulin and LiCl independently and additively increased long-term AAH protein expression.
CONCLUSION: Insulin/IGF-1 stimulation of AAH and Notch are enhanced by inhibiting kinases that could phosphorylate AAH protein. Targeted manipulation of AAH's phosphorylation state may have therapeutic value for reducing AAH-Notch activation and attendant infiltrative growth of hepatocellular carcinomas.

Entities:  

Keywords:  Hepatocellular carcinoma; IGF; Notch; aspartyl-asparaginyl-β-hydroxylase; insulin

Year:  2015        PMID: 26029741      PMCID: PMC4445734     

Source DB:  PubMed          Journal:  J Nat Sci        ISSN: 2377-2700


  41 in total

Review 1.  The two-stage mechanism controlling cellular senescence and immortalization.

Authors:  W E Wright; J W Shay
Journal:  Exp Gerontol       Date:  1992 Jul-Aug       Impact factor: 4.032

2.  Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.

Authors:  M Chiara Cantarini; Suzanne M de la Monte; Maoyin Pang; Ming Tong; Antonia D'Errico; Franco Trevisani; Jack R Wands
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

3.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

4.  Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.

Authors:  Suzanne M de la Monte; Seishu Tamaki; M Chiara Cantarini; Nedim Ince; Marcus Wiedmann; Jade J Carter; Stephanie A Lahousse; Sophia Califano; Takashi Maeda; Takato Ueno; Antonia D'Errico; Franco Trevisani; Jack R Wands
Journal:  J Hepatol       Date:  2006-03-10       Impact factor: 25.083

5.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

6.  Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin.

Authors:  J E Dinchuk; N L Henderson; T C Burn; R Huber; S P Ho; J Link; K T O'Neil; R J Focht; M S Scully; J M Hollis; G F Hollis; P A Friedman
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 7.  Carcinogenesis of primary liver malignancies.

Authors:  R Dürr; W H Caselmann
Journal:  Langenbecks Arch Surg       Date:  2000-04       Impact factor: 3.445

8.  High Throughput Method for Assessment of Cellular Reduced Glutathione in Mammalian Cells.

Authors:  David P Cox; Fernando Cardozo-Pelaez
Journal:  J Environ Prot Sci       Date:  2007-01-01

9.  Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression.

Authors:  Jade J Carter; Ming Tong; Elizabeth Silbermann; Stephanie A Lahousse; Fei Fei Ding; Lisa Longato; Nitin Roper; Jack R Wands; Suzanne M de la Monte
Journal:  Acta Neuropathol       Date:  2008-05-14       Impact factor: 17.088

10.  Impaired placentation in fetal alcohol syndrome.

Authors:  F Gundogan; G Elwood; L Longato; M Tong; A Feijoo; R I Carlson; J R Wands; S M de la Monte
Journal:  Placenta       Date:  2007-12-03       Impact factor: 3.481

View more
  2 in total

1.  Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells.

Authors:  Ming Tong; Jin-Song Gao; Diana Borgas; Suzanne M de la Monte
Journal:  Cell Biol (Henderson, NV)       Date:  2017-06-19

Review 2.  Aspartate β-hydroxylase as a target for cancer therapy.

Authors:  Madiha Kanwal; Michal Smahel; Mark Olsen; Jana Smahelova; Ruth Tachezy
Journal:  J Exp Clin Cancer Res       Date:  2020-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.